The treatment was originally intended to demonstrate the safety of the latest generation of the therapies.
Harvard Medical School scientists have found a compound that in laboratory dishes blocks the dengue virus in two ways.
How has this widely acclaimed biomedical innovator fallen so far, so fast?
It is estimated that almost 600,000 Canadians will experience anaphylaxis in their lifetime and that more than half of the individuals who had anaphylaxis were not equipped with life-saving epinephrine.
Chemists have long dreamed of using similarly cheap and easy techniques to make carbon-to-carbon couplings.
Lawmakers in states across the country have considered or adopted secrecy laws to help ensure a steady supply of lethal injection drugs.
The initiative, announced on Friday, involves sequencing up to 2 million human genomes.
Perrigo said Friday that it would not comment on "speculation or market rumor."
The new mouse model is significant because it closely replicates the symptoms and gene expression patterns found in people who have the most common genetic cause of ALS.
Melbourne researchers have uncovered the genes responsible for the way the body fights infection at the point of 'invasion'.
The first U.N. General Assembly special session to address global drug policy in nearly 20 years heard major differences on the approach to drug use on its second day on Wednesday.
This is the first molecular model of this critical transporter, and could prove important for the development of therapeutic agents that need to be delivered to the brain.
The university reported the test has undergone trials with 38 people, 29 with Parkinson’s and nine without.
Genes and environment determine short-sightedness.
Shares of Novartis were down 0.7 percent at 74.55 Swiss francs in mid-morning trading on the Six Swiss stock exchange.